247 related articles for article (PubMed ID: 26410378)
1. Epigenetic silencing of a long non-coding RNA KIAA0495 in multiple myeloma.
Wong KY; Li Z; Zhang X; Leung GK; Chan GC; Chim CS
Mol Cancer; 2015 Sep; 14():175. PubMed ID: 26410378
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic silencing of LPP/miR-28 in multiple myeloma.
Li Z; Wong KY; Chan GC; Chim CS
J Clin Pathol; 2018 Mar; 71(3):253-258. PubMed ID: 28775176
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic silencing of MIR203 in multiple myeloma.
Wong KY; Liang R; So CC; Jin DY; Costello JF; Chim CS
Br J Haematol; 2011 Sep; 154(5):569-78. PubMed ID: 21707582
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic silencing of miR-340-5p in multiple myeloma: mechanisms and prognostic impact.
Li Z; Wong KY; Calin GA; Chng WJ; Chan GC; Chim CS
Clin Epigenetics; 2019 May; 11(1):71. PubMed ID: 31064412
[TBL] [Abstract][Full Text] [Related]
5. Infrequent DNA methylation of miR-9-1 and miR-9-3 in multiple myeloma.
Zhang Q; Wang LQ; Wong KY; Li ZY; Chim CS
J Clin Pathol; 2015 Jul; 68(7):557-61. PubMed ID: 25855800
[TBL] [Abstract][Full Text] [Related]
6. Insights into epigenetic regulation of microRNA-155 expression in multiple myeloma.
Krzeminski P; Sarasquete ME; Misiewicz-Krzeminska I; Corral R; Corchete LA; Martín AA; García-Sanz R; San Miguel JF; Gutiérrez NC
Biochim Biophys Acta; 2015 Mar; 1849(3):353-66. PubMed ID: 25497370
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic inactivation of the MIR34B/C in multiple myeloma.
Wong KY; Yim RL; So CC; Jin DY; Liang R; Chim CS
Blood; 2011 Nov; 118(22):5901-4. PubMed ID: 21976676
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic dysregulation of Wnt signaling pathway in multiple myeloma.
Chim CS; Pang R; Fung TK; Choi CL; Liang R
Leukemia; 2007 Dec; 21(12):2527-36. PubMed ID: 17882284
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic silencing of EVL/miR-342 in multiple myeloma.
Li Z; Wong KY; Chan GC; Chng WJ; Chim CS
Transl Res; 2018 Feb; 192():46-53. PubMed ID: 29242101
[TBL] [Abstract][Full Text] [Related]
10. [Aberrant micro RNA and epigenetic network are associated with progression from MGUS to multiple myeloma].
Handa H
Rinsho Ketsueki; 2015 Aug; 56(8):981-8. PubMed ID: 26345556
[TBL] [Abstract][Full Text] [Related]
11. Long Noncoding RNA
Handa H; Honma K; Oda T; Kobayashi N; Kuroda Y; Kimura-Masuda K; Watanabe S; Ishihara R; Murakami Y; Masuda Y; Tahara KI; Takei H; Kasamatsu T; Saitoh T; Murakami H
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32992461
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA MALAT1 is an inducible stress response gene associated with extramedullary spread and poor prognosis of multiple myeloma.
Handa H; Kuroda Y; Kimura K; Masuda Y; Hattori H; Alkebsi L; Matsumoto M; Kasamatsu T; Kobayashi N; Tahara KI; Takizawa M; Koiso H; Ishizaki T; Shimizu H; Yokohama A; Tsukamoto N; Saito T; Murakami H
Br J Haematol; 2017 Nov; 179(3):449-460. PubMed ID: 28770558
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic dysregulation of secreted Frizzled-related proteins in multiple myeloma.
Jost E; Gezer D; Wilop S; Suzuki H; Herman JG; Osieka R; Galm O
Cancer Lett; 2009 Aug; 281(1):24-31. PubMed ID: 19299079
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic modifications in multiple myeloma: recent advances on the role of DNA and histone methylation.
Amodio N; D'Aquila P; Passarino G; Tassone P; Bellizzi D
Expert Opin Ther Targets; 2017 Jan; 21(1):91-101. PubMed ID: 27892767
[TBL] [Abstract][Full Text] [Related]
15. DNA methylation of tumor suppressor protein-coding and non-coding genes in multiple myeloma.
Wong KY; Chim CS
Epigenomics; 2015; 7(6):985-1001. PubMed ID: 26417914
[TBL] [Abstract][Full Text] [Related]
16. Aberrant gene methylation implicated in the progression of monoclonal gammopathy of undetermined significance to multiple myeloma.
Chim CS; Liang R; Leung MH; Kwong YL
J Clin Pathol; 2007 Jan; 60(1):104-6. PubMed ID: 17213358
[TBL] [Abstract][Full Text] [Related]
17. Promoter methylation of the bone morphogenetic protein 6 gene in multiple myeloma.
Hashida Y; Nemoto Y; Imajoh M; Murakami M; Taniguchi A; Komatsu N; Yokoyama A; Daibata M
Oncol Rep; 2012 Mar; 27(3):825-30. PubMed ID: 22086350
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic silencing of the tetraspanin CD9 during disease progression in multiple myeloma cells and correlation with survival.
De Bruyne E; Bos TJ; Asosingh K; Vande Broek I; Menu E; Van Valckenborgh E; Atadja P; Coiteux V; Leleu X; Thielemans K; Van Camp B; Vanderkerken K; Van Riet I
Clin Cancer Res; 2008 May; 14(10):2918-26. PubMed ID: 18483358
[TBL] [Abstract][Full Text] [Related]
19. Promoter hypermethylation of the MEG3 (DLK1/MEG3) imprinted gene in multiple myeloma.
Benetatos L; Dasoula A; Hatzimichael E; Georgiou I; Syrrou M; Bourantas KL
Clin Lymphoma Myeloma; 2008 Jun; 8(3):171-5. PubMed ID: 18650181
[TBL] [Abstract][Full Text] [Related]
20. Promoter hypermethylation of tetraspanin members contributes to their silencing in myeloma cell lines.
Drucker L; Tohami T; Tartakover-Matalon S; Zismanov V; Shapiro H; Radnay J; Lishner M
Carcinogenesis; 2006 Feb; 27(2):197-204. PubMed ID: 16113057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
